National Bank of Canada’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-186
Closed -$28.8K 2863
2023
Q3
$28.8K Sell
186
-1
-0.5% -$163 ﹤0.01% 1945
2023
Q2
$26.4K Hold
187
﹤0.01% 1942
2023
Q1
$31.5K Sell
187
-13
-7% -$2.32K ﹤0.01% 1847
2022
Q4
$33.9K Sell
200
-492
-71% -$89.2K ﹤0.01% 1854
2022
Q3
$130K Buy
692
+500
+260% +$105K ﹤0.01% 1466
2022
Q2
$32K Buy
192
+24
+14% +$3.8K ﹤0.01% 1926
2022
Q1
$32K Sell
168
-21,794
-99% -$4.14M ﹤0.01% 2019
2021
Q4
$5.82M Buy
+21,962
New +$5.92M 0.02% 518

Other funds holding RGEN

National Bank of Canada's RGEN Position: Q4 2023 in Review

National Bank of Canada sold out of Repligen (RGEN) in Q4 2023, closing a stake of 186 shares — an estimated $28.8K sold.

National Bank of Canada first reported a position in RGEN in Q4 2021 and held it in 8 quarters. The position peaked at $5.82M in Q4 2021. 467 funds tracked by Wall St. Rank hold RGEN as of Q4 2023.

  • National Bank of Canada reported no remaining Repligen position as of Q4 2023 after selling out during the quarter.
  • National Bank of Canada sold 186 Repligen shares in Q4 2023, an estimated $28.8K.
  • National Bank of Canada first reported a position in Repligen in Q4 2021 and held it in 8 quarters.
  • National Bank of Canada's Repligen position peaked at $5.82M in Q4 2021.
  • 467 funds tracked by Wall St. Rank held Repligen as of Q4 2023.

Based on National Bank of Canada's 13F filing for Q4 2023, filed 6 Feb 2024.